Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.11 percent. This is a 3250 percent decrease over earnings of $0.02 per share from the same period last year.
Cathie Wood’s Flagship Fund Has Traded Lower Every Day In August: What’s Going On?
Cathie Wood's fund, ARK Innovation ETF (ARCA:ARKK) has traded lower every day in August and is now down more than 11% month-to-date. Here's a look at what's going on.
